bioRxivNeurosciencePreprint
Tau-seed interactome analysis reveals distinct functional signatures in Alzheimer's disease across model systems.
Pablo MartíneziD, Henika PateliD, Yanwen YouiD, Daniella Lopes, Armando AmaroiD, Nur JuryiD, Yuhao MiniD, Javier Redding‐OchoaiD, Sayan DuttaiD, Jean‐Christophe RochetiD, Nilüfer Ertekin‐TaneriD, Juan Carlos TroncosoiD, Cristian A. Lasagna‐ReevesiD
Abstract
Tau aggregates propagate through the brain in a prion-like manner in Alzheimers disease (AD) and other tauopathies, but the molecular identity and functional partners of the seeding-competent Tau species remain poorly defined. Here, we present an unbiased proteomic profiling of a high-molecular-weight (HMW) Tau-seed isolated from AD patient brains. We contrast this interactome with that of a biochemically similar, seeding-incompetent HMW-Tau species from age-matched healthy controls. Despite comprising less than 5% of total Tau in the brain, Tau-seed associates with a distinct set of proteins enriched in synaptic, mitochondrial, and vesicle-trafficking functions. Cross-species functional screening in Drosophila and mouse models identifies interactors that modulate Tau toxicity and seeding. Spatially resolved analysis of postmortem AD brains reveals heterogenous co-deposition of these proteins with Tau aggregates, suggesting functionally distinct Tau-seed complexes. Together, this dataset provides a framework for understanding selective Tau-seed toxicity and identifies candidate regulators of Tau propagation with therapeutic potential.
- organism: human
- organism: mouse
- organism: Drosophila
- assay: proteomics
- research focus: cell-cell communication
- research focus: differential expression
- research focus: protein structure prediction
- approach: statistical model
- approach: experimental assay
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Tau seeding without tauopathy
Michael LaCroix, Efrosini Artikis, … Marc I. Diamond·Journal of Biological ChemistryPeer-reviewed·Dec 9, 2023
- Direct binding of TDP-43 and Tau drives their co-condensation, but suppresses Tau fibril formation and seeding
Francesca Simonetti, Weijia Zhong, … Dorothee Dormann·bioRxiv·Jul 7, 2025
- Proximity labeling of the Tau repeat domain enriches RNA-binding proteins that are altered in Alzheimer's disease and related tauopathies
Sarah M. Shapley, Anantharaman Shantaraman, … Nicholas T. Seyfried·Molecular & Cellular ProteomicsPeer-reviewed·Nov 7, 2025
- Tau interactome mapping reveals dynamic processes in synapses and mitochondria associated with neurodegenerative disease
Tara E. Tracy, Jesús Madero‐Pérez, … Li Gan·CellPeer-reviewed·Jan 20, 2022
- Small tau aggregates exhibit disease-specific molecular profiles across tauopathies
Dorothea Böken, Melissa Huang, … David Klenerman·Cell ReportsPeer-reviewed·Feb 1, 2026
- Understanding the complex interplay between tau, amyloid and the network in the spatiotemporal progression of Alzheimer's Disease
Ashish Raj, Justin Torok, Kamalini G. Ranasinghe·Progress in NeurobiologyPeer-reviewed·Mar 17, 2025